EZH2‐mediated downregulation of miR‐155‐5p contributes to prostate cancer cell malignancy through SMAD2 and TAB2

Abstract miR‐155 exhibits variable expression in different tumors and fulfills diverse biological roles. However, specific molecular mechanisms by which miR‐155‐5p, which is under‐expressed in prostate cancer (PCa), operates are yet to be elucidated. The role of the enhancer of zeste 2 (EZH2)/miR‐15...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi‐Jie Bai, Jia‐Yi Liu, Wen‐Zhou Xing, Hai‐Feng Wang
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12936
Tags: Add Tag
No Tags, Be the first to tag this record!